Patient Guide: A Phase 1, randomized, double-blind, single-dose, partial replicate, 3-period cross-over study to assess the total systemic exposure bioequivalence of budesonide and albuterol delivered by BDA MDI Hydrofluoroolefin (HFO) compared with BDA MDI (Hydrofluoroalkene) HFA.

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 1 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT06139991
Status: COMPLETED
Condition: Heathy participants
Phase: Phase I

Find a Study Location Near You

This study is available at 1 research site. We'll help you connect with the location that's right for you.

Participating sites include:
  • Glendale, CA

Loading interactive enrollment tools...

The full interactive experience will load momentarily